Psyence Biomedical Ltd (PBM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 12-2023 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,012 | -51,159 | N/A | N/A | N/A |
| Depreciation Amortization | 4 | 0 | N/A | N/A | N/A |
| Other Working Capital | -386 | -1,173 | N/A | N/A | N/A |
| Other Operating Activity | -4,364 | 49,387 | 0 | 0 | 0 |
| Operating Cash Flow | $-3,734 | $-2,945 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -6 | N/A | N/A | N/A |
| Other Investing Activity | -6 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-16 | $-6 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,000 | 2,500 | N/A | N/A | N/A |
| Common Stock Issued | 1,742 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 6,410 | -150 | 0 | 0 | 0 |
| Financing Cash Flow | $9,152 | $2,350 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 733 | 1,334 | N/A | N/A | N/A |
| End Cash Position | 6,135 | 733 | N/A | N/A | N/A |
| Net Cash Flow | $5,402 | $-601 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,734 | -2,945 | N/A | N/A | N/A |
| Capital Expenditure | -10 | -6 | N/A | N/A | N/A |
| Free Cash Flow | -3,744 | -2,951 | 0 | 0 | 0 |